The Employment of Leukotriene Antagonists in Cutaneous Diseases Belonging to Allergological FieldNETTIS, Eustachio; D'ERASMO, Maddalena; DI LEO, Elisabetta et al.Mediators of inflammation. 2010, Vol 2010, Num 2, issn 0962-9351, 628171.1-628171.6Article

Cysteinyl-leukotriene receptor antagonist, bronchoconstriction, and airway hyperreactivityAALBERS, R; DE MONCHY, J. G. R.Lancet (British edition). 1991, Vol 338, Num 8764, issn 0140-6736, p. 445Article

Premedication with montelukast reduces local reactions of allergen immunotherapyWOHRL, Stefan; GAMPER, Simon; HEMMER, Wolfgang et al.International archives of allergy and immunology. 2007, Vol 144, Num 2, pp 137-142, issn 1018-2438, 6 p.Article

Short-term effects of montelukast in stable patients with moderate to severe COPDCELIK, Pinar; SAKAR, Aysin; HAVLUCU, Yavuz et al.Respiratory medicine. 2005, Vol 99, Num 4, pp 444-450, issn 0954-6111, 7 p.Article

Neuropathy in eosinophilic granulomatosis with polyangiitis: a comparison study of 24 cases with or without prior leukotriene antagonist exposureGIUSTI DEL GIARDINO, L; CAVALLARO, T; ANZOLA, G. P et al.European annals of allergy and clinical immunology. 2014, Vol 46, Num 6, pp 201-209, issn 1764-1489, 9 p.Article

Peptide leukotrienes : current status of researchSHAW, A; KRELL, R. D.Journal of medicinal chemistry (Print). 1991, Vol 34, Num 4, pp 1235-1242, issn 0022-2623, 8 p.Article

Asthma: A brief overviewSHEPHERD, Jinna M; DUDDLESTON, David N; HICKS, G. Swink et al.The American journal of the medical sciences. 2002, Vol 324, Num 4, pp 174-179, issn 0002-9629, 6 p.Article

WF11605, an antagonist of leukotriene B₄ produced by a fungus. II : Structure determinationSHIGEMATSU, N; TSUJII, E; KAYAKIRI, N et al.Journal of antibiotics (Tokyo. 1968). 1992, Vol 45, Num 5, pp 704-708, issn 0021-8820Article

Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodelingHOSHINO, Makoto.Clinical reviews in allergy and immunology. 2004, Vol 27, Num 1, pp 59-64, issn 1080-0549, 6 p.Article

Chromatographic analysis of residual acetate in bulk drugsSEE, M. M; THOMPSON, R; GRINBERG, N et al.Journal of liquid chromatography. 1995, Vol 18, Num 1, pp 137-154, issn 0148-3919Article

Urinary LTE₄ excretion in antigen-provoked asthmatic patients treated with the inhaled LTD₄ antagonists, L-648,051RASMUSSEN, J. B; ERIKSSON, L.-O; TAGARI, P et al.Allergy, European journal of allergy and clinical immunology. 1992, Vol 47, Num 6, pp 599-603Article

Influence of body mass index on the response to asthma controller agentsPETERS-GOLDEN, M; SWERN, A; BIRD, S. S et al.The European respiratory journal. 2006, Vol 27, Num 3, pp 495-503, issn 0903-1936, 9 p.Article

Therapeutic strategies to reduce asthma exacerbationsO'BYRNE, Paul M.Journal of allergy and clinical immunology. 2011, Vol 128, Num 2, pp 257-263, issn 0091-6749, 7 p.Article

Therapeutic modulation of allergic airways disease with leukotriene receptor antagonistsCURRIE, G. P; SRIVASTAVA, P; DEMPSEY, O. J et al.QJM (Oxford. 1994. Print). 2005, Vol 98, Num 3, pp 171-182, issn 1460-2725, 12 p.Article

The Role of Decongestants, Cromolyn, Guafenesin, Saline Washes, Capsaicin, Leukotriene Antagonists, and Other Treatments on RhinitisKUSHNIR, Nataliya M.Immunology and allergy clinics of North America. 2011, Vol 31, Num 3, issn 0889-8561, vii, 601-617 [18 p.]Article

Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: A comparison based on meta-analysesMATRICARDI, Paolo Maria; KUNA, Piotr; PANETTA, Valentina et al.Journal of allergy and clinical immunology. 2011, Vol 128, Num 4, pp 791-799, issn 0091-6749, 9 p.Article

Long-term management of asthmaKABRA, S. K; LODHA, Rakesh.Indian journal of pediatrics. 2003, Vol 70, Num 1, pp 63-72, issn 0019-5456, 10 p.Article

Differential effects of salbutamol and montelukast on eosinophil adhesion and superoxide anion generationKUSHIYA, Mariko; SAITO, Keiko; KIKUCHI, Izumi et al.International archives of allergy and immunology. 2006, Vol 140, pp 17-22, issn 1018-2438, 6 p., SUP1Conference Paper

High-performance liquid chromatographic determination of 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-γ-oxobenzenebutanoic acid and metabolites in human plasmaROTHWELL, C. M; HSIEH, J. Y.-K; BAYNE, W. F et al.Journal of chromatography. 1987, Vol 417, Num 2, pp 447-451, issn 0021-9673Article

Identification of the human cytochrome P450s responsible for the in vitro metabolism of a leukotriene B4 receptor antagonist, CP-195,543KHOJASTEH-BAKHT, S. C; ROSSULEK, M. I; FOUDA, H. G et al.Xenobiotica (London. Print). 2003, Vol 33, Num 12, pp 1201-1210, issn 0049-8254, 10 p.Article

Piriprost: a putative leukotriene synthesis inhibitor increases pulmonary blood flow in fetal lambsLEBIDOIS, J; SOIFER, S. J; CLYMAN, R. I et al.Pediatric research. 1987, Vol 22, Num 3, pp 350-354, issn 0031-3998Article

Potential Role of Leukotriene Modifiers in the Treatment of Chronic Obstructive Pulmonary DiseaseUSERY, Justin B; SELF, Timothy H; MUTHIAH, Muthiah P et al.Pharmacotherapy. 2008, Vol 28, Num 9, pp 1183-1187, issn 0277-0008, 5 p.Article

Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergenDAVIS, Beth E; TODD, David C; COCKCROFT, Donald W et al.Journal of allergy and clinical immunology. 2005, Vol 116, Num 4, pp 768-772, issn 0091-6749, 5 p.Article

A randomized controlled trial of intravenous montelukast in acute asthmaCAMARGO, Carlos A; SMITHLINE, Howard A; MALICE, Marie-Pierre et al.American journal of respiratory and critical care medicine. 2003, Vol 167, Num 4, pp 528-533, issn 1073-449X, 6 p.Article

Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigsLEICK-MALDONADO, E. A; KAY, F. U; LEONHARDT, M. C et al.Clinical and experimental allergy (Print). 2004, Vol 34, Num 1, pp 145-152, issn 0954-7894, 8 p.Article